|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Fortovase
Roche Posts Strong First Quarter Sales – Upgrade of Core Earnings ... - Apr 18, 2007 PharmaLive.com (press release),Sales of the HIV medicine Fuzeon increased by 12%, and Invirase/Fortovase by 23%. CellCept sales rose by 7% and remained the top-selling branded
YM BioSciences Strengthens Program Management of Lead Drugs - Apr 5, 2007 Drug Newswire (press release),La-Roche Inc. with leadership responsibility through NDA filings and certain of the approvals for Xeloda(TM), Fortovase(TM), Zenapax(TM), Xenical(TM).
Exploiting natural HIV defence - Feb 9, 2007 BiopharmaReporter.com,Next came HIV protease inhibitors such as Roche's Invirase/Fortovase (saquinavir), Abbott Laboratories Norvir (ritonavir), Merck & Co's Crixivan (indinavir)
Roche Posts Outstanding Results for 2006 - Feb 7, 2007 PharmaLive.com (press release),Combined sales of Invirase and Fortovase (saquinavir) increased 28% to 182 million Swiss francs. Growth is being fuelled by increasing uptake of the
NGN Capital's Managing General Partner Georg Nebgen Joins Javelin ... - Dec 11, 2006 American Digital Networks (press release),...from F. Hoffmann-La Roche, where he led as Technical Project Leader global research & development team activities for Invirase/Fortovase.
Panacos Announces New Board Member Oct 27, 2006 ...was Medical Director for Hoffmann-LaRoche's Virology Group, where he was involved in the launch of INVIRASE and developed FORTOVASE, protease inhibitors for ... -PharmaLive.com (press release),
NGN Capital’s Managing General Partner Georg Nebgen Joins Javelin ... - Dec 11, 2006 Business Wire (press release),...from F. Hoffmann-La Roche, where he led as Technical Project Leader global research & development team activities for Invirase/Fortovase.
Roche AIDS drug may be pulled out of India Aug 10, 2006 ...the wholly-owned subsidiary of Swiss drug maker F Hoffmann-La Roche & Co (Roche), is likely to withdraw its anti-HIV AIDS drug Fortovase (Saquinavir) from the ... -Financial Express
Roche to put AIDS drug off Indian shelves Aug 10, 2006 After withdrawing its HIV AIDS drug from Europe, Roche India is likely to discontinue manufacturing the Fortovase (Saquinavir) from the Indian market as well ... -Myiris.com
Large analysis shows benefits of starting treatment with efavirenz Aug 22, 2006 The boosted protease inhibitors included were amprenavir (Agenerase), lopinavir (Kaletra), saquinavir (Invirase / Fortovase) and indinavir (Crixivan): newer ... -Aidsmap
Roche discontinues marketing of anti-HIV drug Fortovase Feb 8, 2006 Following through on plans announced in late 2005, drugmaker Roche on Monday halted US sales of its HIV protease inhibitor Fortovase, citing low demand for the ... - The Advocate,
Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 6 /PRNewswire/ -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase(R), the soft ... - International News Service,
UPDATE 1-Roche to discontinue US sales of AIDS drug Feb 6, 2006 YORK, Feb 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Monday it will discontinue US sales of its HIV drug Fortovase as another ... - Reuters
Roche discontinues marketing of anti-HIV drug Fortovase 09 Feb 2006 Following through on plans announced in late 2005, drugmaker Roche on Monday halted US sales of its HIV protease inhibitor Fortovase, citing low demand for the ... - The Advocate
Roche to discontinue HIV treatment 09 Feb 2006 Swiss drug manufacturer Roche is to discontinue US sales of its HIV protease inhibitor Fortovase, a soft-gel formulation of the active ingredient saquinavir. ... - Pharmaceutical Business Review
Roche To Stop Selling Protease Inhibitor Fortovase Because of ... Feb 8, 2006 15 it will stop selling its protease inhibitor Fortovase -- known generically as saquinavir -- in the US because of decreased demand for the drug and increased ... - Kaiser network.org
Roche to Focus Resources on Availability of Invirase, Now ... Feb 6, 2006 February 6, 2006 -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase®, the soft ... - DG News
Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 6 /PRNewswire/ -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase(R), the soft ... - International News Service
UPDATE 1-Roche to discontinue US sales of AIDS drug Feb 6, 2006 YORK, Feb 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Monday it will discontinue US sales of its HIV drug Fortovase as another ... - Reuters
Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 ...- Company Voluntarily Ceases Sale and Distribution of Fortovase(R) In the US - NUTLEY, NJ, Feb. 6 /PRNewswire/ -- Roche today announced ... - PR Newswire
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|